The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response-Reference-Cited by-同舟云学术

The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response

Published:2023-02 Issue:7 Volume:41 Page:1310-1318
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Myers Tanya R.,Marquez Paige L.,Gee Julianne M.,Hause Anne M.,Panagiotakopoulos Lakshmi,Zhang Bicheng,McCullum Isaac,Licata Charles,Olson Christine K.,Rahman Shakeeb,Kennedy Sharon B.,Cardozo Matthew,Patel Chirayu R.,Maxwell Liza,Kallman Joel R.,Shay David K.,Shimabukuro Tom T.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference23 articles.

1. The Emergency Use Authorization of pharmaceuticals: history and utility during the COVID-19 pandemic;Tran;Pharmaceut Med,2021

2. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS);Shimabukuro;Vaccine,2015

3. The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety;McNeil;Vaccine,2014

4. U.S. Food & Drug Administration (2021, July 12). COVID-19 vaccine safety surveillance. U.S. Department of Health & Human Services. https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/covid-19-vaccine-safety-surveillance#CMS Accessed Jun 3, 2022.

5. Preliminary findings of mRNA COVID-19 vaccine safety in pregnant persons;Shimabukuro;N Engl J Med,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reflections on the Advisory Committee on Immunization Practices During the COVID-19 Pandemic;Academic Pediatrics;2024-09

2. Comparative safety of monovalent and bivalent mRNA COVID-19 booster vaccines in adolescents aged 12 to 17 years in the Republic of Korea;Osong Public Health and Research Perspectives;2024-08-31

3. Cohort event monitoring of safety of COVID-19 vaccines: the Italian experience of the “ilmiovaccinoCOVID19 collaborating group”;Frontiers in Drug Safety and Regulation;2024-08-12

4. Trends in the administration of COVID-19 vaccines with other vaccines in the United States reported to V-safe during December 14, 2020—May 19, 2023;Human Vaccines & Immunotherapeutics;2024-06-07

5. JYNNEOS vaccine safety surveillance during the 2022 mpox outbreak using the Vaccine Adverse Event Reporting System (VAERS) and v-safe, United States, 2022—2023;Sexually Transmitted Diseases;2024-04-19